Specific Treatment Issues for Pregnant Women With HIV
 Nutrition and HIV for Moms-to-Be (December 5, 2012)
From TheBody.com
- Keeping My Promise; Loving My Self (March 6, 2012)
From Black AIDS Institute
- Reyataz (Atazanavir) Label Revised, Adding Dosing Recommendations for Pregnancy and Postpartum Period (February 4, 2011)
From U.S. Food and Drug Administration
- Women With HIV Deserve Abortion Coverage: Tell the White House! (October 5, 2010)
From Positive Women's Network of the United States of America
- Taking HIV Meds Throughout Pregnancy Does More Good Than Harm, Study Suggests (September 15, 2008)
From aidsmap.com
- HIV Meds During Pregnancy Do Not Increase Birth Defect Risk, Major Study Finds (March 27, 2007)
- Six-Month Delay in Onset of Nevirapine-Based Antiretroviral Therapy Can Prevent Drug Resistance Following Single-Dose Nevirapine During Labor, Study Says (January 11, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Exposure to ARVs in Womb Does Not Affect Child's Mental Development, Canadians Report (October 31, 2006)
From aidsmap.com
- Nevirapine Resistance May Persist in Some Pregnant Women, Study Finds (May 3, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
- Efavirenz-Associated Neural Tube Defects Reported in Infants; Pregnancy Category Changed From C to D (March 31, 2005)
From U.S. Food and Drug Administration
VIEW ALL ARTICLES
|
Advertisement
|
Email
Glossary
